Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It has become increasingly clear that trauma responses are defined less so by stressor-related factors and more so by individual-level factors, such as alterations in immune and inflammatory functioning. In this chapter, we begin with a summary and review of the prevalence, diagnostic characterization, and neurobiological etiology of Posttraumatic Stress Disorder (PTSD), presenting theory and research that describe the neuro-endocrinological, neurochemical, and neuroanatomical basis for PTSD. We then present evidence detailing the modulating and mediating roles of tryptophan derivatives (kynurenic acid, quinolinic acid, serotonin and melatonin) on the pathophysiology of disordered neurobiological and neuroinflammatory responses to fear/anxiety. Finally, we discuss both pharmacologic and non-pharmacologic therapeutic approaches that may be used in the treatment of PTSD.

Original publication

DOI

10.1016/B978-0-12-822790-9.00007-3

Type

Chapter

Book title

Biophotonics Tryptophan and Disease

Publication Date

01/01/2021

Pages

93 - 105